共 50 条
- [21] Improvements in Dysphagia and Pain With Swallowing in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral SuspensionCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (04) : 699 - +Dellon, Evan S.Collins, Margaret H.Katzka, David A.Hudgens, StacieLan, LanWilliams, JamesVera-Llonch, MontserratHirano, Ikuo
- [22] Determination of the Eosinophilic Esophagitis Endoscopic Reference Score Associated With Histologic Response to Therapy: Analysis From a Phase 3 Placebo-Controlled Trial of Budesonide Oral SuspensionAMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S217 - S218Hirano, IkuoCollins, Margaret H.Katzka, David A.Mukkada, Vincent A.Falk, Gary W.Williams, James E.Desai, Nirav K.Lan, LanDellon, Evan S.
- [23] Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic EsophagitisJOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (06): : 760 - 768Mukkada, Vincent A.Gupta, Sandeep K.Gold, Benjamin D.Dellon, Evan S.Collins, Margaret H.Katzka, David A.Falk, Gary W.Williams, JamesZhang, WenwenBoules, MenaHirano, IkuoDesai, Nirav K.
- [24] Budesonide Oral Suspension Improves Histologic Features In Patients With Eosinophilic Esophagitis: Results From A Phase 3, Randomized, Double-blind, Placebo-Controlled TrialJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB166 - AB166Collins, MargaretHirano, IkuoKatzka, DavidCianferoni, AntonellaWilliams, JamesDesai, NiravLan, LanDellon, Evan
- [25] Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis in Adolescents and Adults: Results From a Phase 3, Randomized, Placebo-Controlled TrialAMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S205 - S206Hirano, IkuoCollins, Margaret H.Katzka, David A.Mukkada, Vincent A.Falk, Gary W.Williams, JamesDesai, Nirav K.Lan, LanMorey, RobinDellon, Evan S.
- [26] A Population Pharmacokinetic Analysis of Budesonide Oral Suspension in Children and Adults With Eosinophilic Esophagitis and Healthy Adult VolunteersAMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S220 - S220Song, Ivy H.Rodgers, TrudyHayes, SiobhanFarrell, Colm
- [27] Mucosal Contact Time Determines Histologic Effectiveness of Oral Budesonide Preparations in Eosinophilic Esophagitis: A Randomized Trial Using ScintigraphyGASTROENTEROLOGY, 2012, 142 (05) : S180 - S180Dellon, Evan S.Sheikh, ArifWhitlow, AnnIvanovic, MarijaChau, AllenWoodward, KimberlySpeck, OlgaHores, JessicaWoosley, John T.Madanick, Ryan D.Orlando, Roy C.Shaheen, Nicholas J.
- [28] ENDOSCOPIC FEATURES ARE SIGNIFICANTLY ASSOCIATED WITH HISTOLOGIC MEASURES OF DISEASE ACTIVITY IN PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS: A POST HOC ANALYSIS OF A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 DUPILUMAB TRIALGASTROENTEROLOGY, 2018, 154 (06) : S243 - S244Hirano, IkuoCollins, Margaret H.Dellon, Evan S.Rothenberg, Marc E.Schoepfer, Alain M.Chehade, MirnaChen, ZhenMannent, LedaGraham, Neil M.Pirozzi, GianlucaHamilton, Jennifer D.Radin, Allen
- [29] BUDESONIDE ORAL SUSPENSION (BOS) IMPROVES ENDOSCOPIC ACTIVITY IN ADOLESCENTS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS AND CORRELATION ANALYSIS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALGASTROENTEROLOGY, 2020, 158 (06) : S42 - S43Hirano, IkuoCollins, Margaret H.Katzka, David A.Mukkada, Vincent A.Falk, Gary W.Williams, JamesDesai, Nirav K.Lan, LanDellon, Evan S.
- [30] Randomized, Double-Blind, Placebo Controlled Trial Demonstrates the Efficacy of Oral Budesonide Suspension in Improving Endoscopically Identified Esophageal Abnormalities in Eosinophilic EsophagitisGASTROENTEROLOGY, 2015, 148 (04) : S29 - S30Hirano, IkuoKatzka, David A.Collins, Margaret H.Dellon, Evan S.